Page last updated: 2024-10-25

deferoxamine and Neuromuscular Diseases

deferoxamine has been researched along with Neuromuscular Diseases in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sprague, SM1
Corwin, HL1
Tanner, CM1
Wilson, RS1
Green, BJ1
Goetz, CG1

Other Studies

1 other study available for deferoxamine and Neuromuscular Diseases

ArticleYear
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
    Archives of internal medicine, 1988, Volume: 148, Issue:10

    Topics: Adult; Aluminum; Body Burden; Cognition Disorders; Deferoxamine; Female; Humans; Male; Middle Aged;

1988